Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhou, Chunxiao ^a   Steplowski, Tara A ^a   Dickens, Hallum K ^a   Malloy, Kimberly M ^a   Gehrig, Paola A ^a   Boggess, John F ^a   Bae Jump, Victoria L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UO 126;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; ISHIKAWA CELL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

BUTADIENES; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 84873604038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055730     Document Type: Article

References (38)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE, (2006) Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines. Gynecol Oncol 103: 417-424.
3. Deng Y, Chang S, (2007) Role of telomeres and telomerase in genomic instability, senescence and cancer. Lab Invest 87: 1071-1076.
4. Yu GL, Bradley JD, Attardi LD, Blackburn EH, (1990) In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132.
5. Baykal A, Rosen D, Zhou C, Liu J, Sahin AA, (2004) Telomerase in breast cancer: a critical evaluation. Adv Anat Pathol 11: 262-268.
6. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F, (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884.
7. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
8. Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, et al. (2001) Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res 61: 5529-5536.
9. Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M, (1999) Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 80: 60-63.
10. Menon MM, Simha MR, (2003) Telomerase and telomere length in normal and malignant human endometrium as prognostic markers. Indian J Pathol Microbiol 46: 394-398.
11. Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, et al. (2002) Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 84: 120-125.
12. Ebina Y, Yamada H, Fujino T, Furuta I, Sakuragi N, et al. (1999) Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma. Int J Cancer 84: 529-532.
13. Williams CD, Boggess JF, LaMarque LR, Meyer WR, Murray MJ, et al. (2001) A prospective, randomized study of endometrial telomerase during the menstrual cycle. J Clin Endocrinol Metab 86: 3912-3917.
14. Tanaka M, Kyo S, Takakura M, Kanaya T, Sagawa T, et al. (1998) Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation. Am J Pathol 153: 1985-1991.
15. Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, et al. (2004) Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23: 4505-4515.
16. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, et al. (1999) Estrogen activates telomerase. Cancer Res 59: 5917-5921.
17. Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, et al. (2000) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol 20: 3764-3771.
18. Cong YS, Wen J, Bacchetti S, (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8: 137-142.
19. Lee H, Jiang F, Wang Q, Nicosia SV, Yang J, et al. (2000) MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol Endocrinol 14: 1882-1896.
20. Kato S, (2001) Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 8: 3-9.
21. Cheskis BJ, Greger JG, Nagpal S, Freedman LP, (2007) Signaling by estrogens. J Cell Physiol 213: 610-617.
22. Kurarmoto H, Hamano M, Imai M, (2002) HEC-1 cells. Hum Cell 15: 81-95.
23. Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K, (1985) [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. Nihon Sanka Fujinka Gakkai Zasshi 37: 1103-1111.
24. Lessey BA, Vendrov AE, Yuan L. (2003. p. 267-79.) Endometrial cancer cells as models to study uterine receptivity. In: Kuramoto, H., Nishida, M., editors. Cell and Molcular Biology of Endometrial Carcinoma, Tokyo: Springer-Verlag. 267-279 p.
25. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, et al. (2000) Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6: 452-459.
26. Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N, (2007) Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. Exp Cell Res 313: 3486-3496.
27. Gao H, Dahlman-Wright K, (2011) The gene regulatory networks controlled by estrogens. Mol Cell Endocrinol 334: 83-90.
28. Marino M, Distefano E, Caporali S, Ceracchi G, Pallottini V, et al. (2001) beta-estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J Cell Physiol 188: 170-177.
29. Tzukerman M, Shachaf C, Ravel Y, Braunstein I, Cohen-Barak O, et al. (2000) Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter. Mol Biol Cell 11: 4381-4391.
30. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, et al. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557.
31. Horikawa I, Cable PL, Afshari C, Barrett JC, (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59: 826-830.
32. Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS, (2011) Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol Cell Biol 31: 226-236.
33. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, et al. (2008) Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22: 2116-2127.
34. Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, et al. (2000) Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 60: 5376-5381.
35. Yang SH, Yates PR, Whitmarsh AJ, Davis RJ, Sharrocks AD, (1998) The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol 18: 710-720.
36. Merchant JL, Du M, Todisco A, (1999) Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 254: 454-461.
37. Cruzalegui FH, Cano E, Treisman R, (1999) ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 18: 7948-7957.
38. Ge Z, Liu C, Bjorkholm M, Gruber A, Xu D, (2006) Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation. Mol Cell Biol 26: 230-237.